Duopharma Biotech Fortifies Ethical Culture With ISO37001

KUALA LUMPUR, March 12 (Bernama) -- Malaysia’s leading pharmaceutical company Duopharma Biotech Bhd has achieved ISO37001, an international standard which recognises the existence of an effective anti-bribery management system. The company said all subsidiary companies under the group including its overseas subsidiaries in Singapore and the Philippines also attained ISO37001, which was carried out by SIRIM QAS International Sdn Bhd and included the remarkable note that not even a single non-conformance report was issued by the auditors.   Duopharma Biotech also became the first pharmaceutical company in Malaysia to receive the Five Petal Business Ethics Institute of Malaysia (BEIM) Gold Ethics Award in recognition of its ethics and integrity initiatives last year.  Group managing director Leonard Ariff Abdul Shatar said in a statement that the ISO37001 achievement and BEIM award constituted further testament to Duopharma Biotech’s proactive commitment to promulgating a culture of ethics and integrity. Consistent with this commitment, Duopharma Biotech has established policies and guidelines, which include a series of ethics and integrity policies, corruption risk management and anti-bribery & anti-corruption policies as well as its whistle-blowing policy.  -- BERNAMA